Diminazene is a broad-spectrum antiprotozoal agent traditionally used for the treatment of blood protozoan infections. It is effective against trypanosomes, piroplasms (including Babesia and Theileria species), and anaplasmas (formerly referred to as "edge bodies" or Ehrlichia). It is primarily used to treat trypanosomiasis, such as Surra (caused by Trypanosoma evansi) in horses and camels, and Babesiosis and Theileriosis in livestock. However, it has poor prophylactic efficacy, and both trypanosomes and piroplasms can develop resistance when suboptimal doses are administered. Due to its high toxicity and narrow safety margin, it is not recommended for use in camels, and caution is required when administering high doses to horses or repeated doses to water buffalo.